Amgen's expenditure on research and development 2006-2023
Amgen's R&D expenses amounted to approximately 4.8 billion U.S. dollars in 2023. This statistic shows the expenditure on research and development of biotech company Amgen from 2004 to 2023. Amgen is a U.S.-based multinational biopharmaceutical company, headquartered in Thousand Oaks, California.